Related Experiment Video
Updated: Jun 17, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Microglia specific alternative splicing alterations in multiple sclerosis
Caiyun Qi1, Honglei Ren2, Yong Fan1
1Department of Obstetrics and Gynecology; Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Abstract:
Several aberrant alternative splicing (AS) events and their regulatory mechanisms are widely recognized in multiple sclerosis (MS). Yet the cell-type specific AS events have not been extensively examined. Here we assessed the diversity of AS events using web-based RNA-seq data of sorted CD15-CD11b+ microglia in white matter (WM) region from 10 patients with MS and 11 control subjects. The GSE111972 dataset was downloaded from GEO and ENA databases, aligned to the GRCh38 reference genome from ENSEMBL via STAR. rMATS was used to assess five types of AS events, alternative 3'SS (A3SS), alternative 5'SS (A5SS), skipped exon (SE), retained intron (RI) and mutually exclusive exons (MXE), followed by visualizing with rmats2sashimiplot and maser. Differential genes or transcripts were analyzed using the limma R package. Gene ontology (GO) analysis was performed with the clusterProfiler R package. 42,663 raw counts of AS events were identified and 132 significant AS events were retained based on the filtered criteria: 1) average coverage >10 and 2) delta percent spliced in (ΔPSI) >0.1. SE was the most common AS event (36.36%), followed by MXE events (32.58%), and RI (18.94%). Genes related to telomere maintenance and organization primarily underwent SE splicing, while genes associated with protein folding and mitochondrion organization were predominantly spliced in the MXE pattern. Conversely, genes experiencing RI were enriched in immune response and immunoglobulin production. In conclusion, we identified microglia-specific AS changes in the white matter of MS patients, which may shed light on novel pathological mechanisms underlying MS.
Insights
This study reveals cell-type specific alternative splicing (AS) changes in microglia from multiple sclerosis (MS) patients. These findings highlight novel molecular mechanisms in MS white matter pathology.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Aberrant alternative splicing (AS) is implicated in multiple sclerosis (MS) pathogenesis.
- Cell-type specific AS events in MS remain underexplored, particularly in microglia.
Purpose of the Study:
- To investigate cell-type specific alternative splicing (AS) events in microglia from the white matter of MS patients.
- To identify novel molecular pathways and potential therapeutic targets in MS.
Main Methods:
- Utilized RNA-sequencing data from sorted CD15-CD11b+ microglia of MS patients and controls.
- Applied rMATS to identify five types of AS events: A3SS, A5SS, SE, RI, and MXE.
- Performed differential gene expression analysis and Gene Ontology (GO) enrichment analysis.
Main Results:
- Identified 132 significant AS events in microglia from MS patients.
- Skipped exon (SE) was the most prevalent AS event, followed by mutually exclusive exons (MXE) and retained introns (RI).
- Genes involved in telomere maintenance (SE), protein folding/mitochondrion organization (MXE), and immune response (RI) showed distinct AS patterns.
Conclusions:
- Discovered microglia-specific AS alterations in the white matter of MS patients.
- These AS changes may contribute to MS pathogenesis.
- Provides insights into novel pathological mechanisms and potential therapeutic strategies for MS.
More Related Videos
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

